Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals

BACKGROUND/AIMS: Undetectable HCV RNA 12 weeks after the end of treatment (SVR12) has been the valid efficacy endpoint in the era of direct-acting antivirals (DAAs). Its concordance with SVR4 and SVR24 and long-term durability is unknown in Taiwanese chronic hepatitis C (CHC) patients. METHODS: A to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chuan-Pin, Liang, Po-Cheng, Huang, Ching-I, Yeh, Ming-Lun, Hsu, Po-Yao, Hsu, Cheng-Ting, Wei, Yu-Ju, Liu, Ta-Wei, Hsieh, Ming-Yen, Hou, Nai-Jen, Jang, Tyng-Yuang, Lin, Yi-Hung, Wang, Chih-Wen, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Chung-Feng, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Yu, Ming-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861540/
https://www.ncbi.nlm.nih.gov/pubmed/33539408
http://dx.doi.org/10.1371/journal.pone.0245479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861540/
https://www.ncbi.nlm.nih.gov/pubmed/33539408
http://dx.doi.org/10.1371/journal.pone.0245479

Ejemplares similares